RECRUITING

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Description

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Study Overview

Study Details

Study overview

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Condition
Deviated Nasal Septum
Intervention / Treatment

-

Contacts and Locations

Gainesville

UF Health of University of Florida, Gainesville, Florida, United States, 32610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient presenting for open or endoscopic septorhinoplasty
  • * Age 18-80
  • * Normal oral food and water intake before surgery
  • * ASA physical classification 1-3
  • * Refusal to consent
  • * Patients without a cellular phone or who are unable to accept text messages
  • * Allergy to opioid narcotics
  • * ASA physical classification of 4 or higher
  • * Patient requires other surgery in addition to septorhinoplasty
  • * Age \> 80 or \<18
  • * Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months
  • * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
  • * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
  • * Pregnant women

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Florida,

Jeffrey D Johnson, MD, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

2025-12